Aurobindo Pharma Ltd. logo

Aurobindo Pharma Ltd. (AUROPHARMA)

Market Closed
10 Aug, 10:00
XNSE XNSE
1,648. 00
-10
-0.6031%
726.06B Market Cap
- P/E Ratio
6% Div Yield
1.16M Volume
- Eps
1,658
Previous Close
Add Transaction
Day Range
1,635.2 1,671.9
Year Range
1,016.1 1,671.9
Want to track AUROPHARMA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

AUROPHARMA closed today lower at ₹1,648, a decrease of -0.6031% from yesterday's close, completing a monthly increase of 4.3897% or ₹69.3. Over the past 12 months, AUROPHARMA stock gained 38.4874%.
AUROPHARMA pays dividends to its shareholders, with the most recent payment made on Aug 21, 2025. The next estimated payment will be in In 1 weeks on Aug 21, 2026 for a total of ₹4.
The last earnings report, released on May 25, 2026, missed the consensus estimates by -17.3%. On average, the company has fell short of earnings expectations by -16.1433%, based on the last three reports.
Aurobindo Pharma Ltd. has completed 5 stock splits, with the recent split occurring on Jul 20, 2015.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on XNSE (INR).

AUROPHARMA Chart

People also search for

Sun Pharmaceutical Industries Ltd.
1,944.4
-0.0308%
Tata Motors Ltd.
347.1
+0.0288%
Maruti Suzuki India Limited
14,097
+0.4274%
M&M
Mahindra & Mahindra Ltd.
3,517
+0.4283%
Bajaj Auto Limited
11,677
+0.1286%

Aurobindo Pharma Ltd. (AUROPHARMA) FAQ

What is the stock price today?

The current price is ₹1,648.00.

On which exchange is it traded?

Aurobindo Pharma Ltd. is listed on XNSE.

What is its stock symbol?

The ticker symbol is AUROPHARMA.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 6%.

What is its market cap?

As of today, the market cap is 726.06B.

Has Aurobindo Pharma Ltd. ever had a stock split?

Aurobindo Pharma Ltd. had 5 splits and the recent split was on Jul 20, 2015.

Aurobindo Pharma Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Dr. Makkapati Satakarni B.E., M.B.A., Ph.D. CEO
XNSE Exchange
Y04527142 CUSIP
India Country
26,015 Employees
8 Aug 2025 Last Dividend
10 Feb 2011 Last Split
- IPO Date

Overview

Aurobindo Pharma Limited is a prominent biopharmaceutical company that specializes in the manufacturing of generic formulations and active pharmaceutical ingredients (APIs) for a global market. Founded in 1986, the company has established its headquarters in Hyderabad, India, and extends its reach across several key international markets including the United States of America, Europe, and Puerto Rico. Aurobindo Pharma is dedicated to providing a vast range of pharmaceutical products that cater to various therapeutic areas, thereby playing a pivotal role in enhancing global healthcare.

Products and Services

  • Generic Formulations

    Aurobindo Pharma offers a diverse portfolio of generic formulations encompassing oral solids, liquids, injectables, and vaccines. The company also produces over-the-counter drugs, ensuring wide accessibility to quality medicines for various health conditions.

  • Active Pharmaceutical Ingredients (APIs)

    The company manufactures a wide array of APIs, providing essential components for many drugs across different therapeutic categories. These include crucial areas such as the central nervous system, cardiovascular diseases, and antibiotics, among others.

  • Biosimilars

    Aurobindo develops biosimilars, which are biologically similar products to already approved biological medicines, offering alternatives that can be more cost-effective while maintaining the same efficacy and safety profiles as their reference products.

  • Biocatalysts, Peptides, and Hormones

    Dedicated to innovation, Aurobindo Pharma also focuses on the production of biocatalysts, peptides, and hormones, targeting critical therapeutic areas like anti-retrovirals, anti-diabetics, and gastroenterology.

  • Antiretroviral Drugs

    The company is committed to the global fight against HIV, providing antiretroviral drugs to support both adults and children living with HIV. This endeavor represents Aurobindo Pharma’s dedication to addressing global health crises through effective treatments.

  • Contract Chemistry Services

    Aurobindo Pharma offers project-based chemistry contract services, which encompass a wide range of services from the clinical stage through to manufacturing. This includes managing the entire lifecycle of a drug in the API space, specializing in sterile and non-sterile penicillins, cephalosporins, penems, and non-beta lactams. Through these services, Aurobindo Pharma facilitates the development and production of pharmaceuticals, supporting companies in bringing effective medicines to market.

Contact Information

Address: Galaxy, Plot No. 1
Phone: 91 40 6672 5000